Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The combination therapy effectively treats infertility in PCOS without major side effects.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

Black cumin oil-based carriers improve psoriasis treatment better than standard creams.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Baricitinib shows promise for treating various skin conditions beyond alopecia areata.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

Ixekizumab quickly and effectively clears palmoplantar psoriasis in both adults and children.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

The cream with xyloglucan, pea protein, and cactus extract works as well as the standard treatment for psoriasis and is well-tolerated.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Topical IKKα inhibitors may help prevent CCS tumours.

New micelle solutions greatly improve skin delivery of certain antifungal drugs.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Nirogacestat can cause severe skin issues like hidradenitis suppurativa.